Currently out of the existing stock ratings of David Maris, 44 are a BUY (50%), 35 are a HOLD (39.77%), 9 are a SELL (10.23%).

David Maris

Work Performance Price Targets & Ratings Chart

Analyst David Maris, carries an average stock price target met ratio of 45.06% that have a potential upside of 18.49% achieved within 293 days. Previously, David Maris worked at WELLS FARGO, BMO.

David Maris’s has documented 181 price targets and ratings displayed on 20 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BHC, Bausch Health Companies at 22-Jan-2020.

Wall Street Analyst David Maris

Analyst best performing recommendations are on SIEN (SIENTRA).
The best stock recommendation documented was for SIEN (SIENTRA) at 3/14/2019. The price target of $90 was fulfilled within 4 days with a profit of $6.6 (7.91%) receiving and performance score of 19.78.

Average potential price target upside

of $35.94 (25.45%) on AGN (ALLERGAN PLC).
of $31.19 (22.13%) on JAZZ (JAZZ PHARMACEUTICALS PLC).
of $15.07 (62.53%) on BHC (BAUSCH HEALTH COMPANIES).

AGN Allergan plc EBS Emergent Biosolutions MNK Mallinckrodt plc MYL Viatris PRGO Perrigo Company PLC TEVA Teva Pharma Industries Ltd ADR BHC Bausch Health Companies JAZZ Jazz Pharmaceuticals PLC FLXN Flexion Therapeutics IRWD Ironwood Pharmaceuticals NEOS Neos Therapeutics VTRS Viatris AMPH Amphastar P MDWD Mediwound Ltd SIEN Sientra EOLS Evolus KALA Kala Pharmaceuticals OSMT Osmotica Pharmaceuticals plc RVLP RVL Pharmaceuticals PLC OS OneStream, Common Stock

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Gregg Gilbert (TRUIST)